Message from the Section Chief
The General Thoracic Surgery division of NewYork-Presbyterian Hospital/Columbia University Medical Center (NYPH/Columbia) provides the most compassionate patient care while offering the most advanced surgeries and therapies for chest diseases. We successfully manage every condition—from the extremely common to the very rare and life threatening.
When you come to NYPH/Columbia, you will be treated by a multidisciplinary team that considers every aspect of your diagnosis, treatment and rehabilitation, and has in its arsenal, all the latest medical and surgical techniques.
Our thoracic surgeons are world-class experts in the treatment of lung cancer and emphysema, and NYPH/Columbia continues to be the premier lung transplant center in the New York metropolitan area.
Our advanced technology allows us to perform a high proportion of thoracic procedures using minimal access surgery. This translates into shorter hospital stays and faster recovery times.
You will also receive the benefits of 75 years of innovation—during which we have developed new approaches to tuberculosis, lung cancer, chest wall deformities, myasthenia gravis, emphysema, complex tracheal surgery, and end-stage lung disease. In recent years, we have also made significant progress with lung-sparing and lung-preserving techniques.
Today we lead the way in early lung cancer screening for at-risk individuals, adding years to their lives with early intervention. Our team is leading the nation in the use of personalized medicine, which employs targeted treatment strategies based on a tumor's specific molecular characteristics. We continue to develop less invasive methods to diagnose and biopsy tissue for analysis, and to guide patients to clinical trials and drugs tailored to the genetic analysis of their tumors.
Our Center for Acute Respiratory Failure is breaking new ground, using the latest lung bypass technology to rescue patients whose lungs are rapidly shutting down.
In addition, our surgeons are discovering ways to restore lungs that are too damaged to be used for transplant. A new method of reviving donor lungs will greatly increase the pool of viable organs in the years ahead.
I invite you to learn more about our nationally recognized Center of Excellence, our full spectrum of capabilities and our highly dedicated team.
Tim Sweeney's Story
At age 31, cystic fibrosis patient Timothy Sweeney needed a double lung transplant. Less than one year later, he ran the New York
City Marathon with his transplant surgeon, Joshua Sonett, MD. Hear his story here.